Marcel Wubbolts will assume the position of Chief Technology Officer for DSM as of October 1. Wubbolts, currently Vice President R&D DSM Innovation Center, will report to Rob van Leen, Chief Innovation Officer, and will succeed Jos Put who will continue to be an advisor to DSM.
Marcel Wubbolts holds a PhD from the University of Groningen, The Netherlands, and was post-doc and Assistent Professor at the ETH Zürich, Switzerland, before he joined DSM as a senior scientist and became Managing Director of DSM Biotech GmbH, Jülich, Germany. Thereafter, he was Competence Manager Biocatalysis & Biotransformations and currently is Program Director at the DSM Innovation Center in Delft, The Netherlands, running the Industrial (White) Biotechnology program.
He has published over 80 publications and patents in the area of biocatalysis and metabolic engineering and serves among others on the board of the WG Applied Biocatalysis of the Dutch Society for Biotechnology (NBV) and leads the Industrial Biotechnology Section of Suschem, European Technology Platform for Sustainable Chemistry.
- DSM, Heerlen, The Netherlands
- 3.0.CO;2-G” target=”_blank”>DOI: 10.1002/1522-2640(200205)74:5<694::AID-CITE694>3.0.CO;2-G